Lung cancer treatment patterns and costs in Canada
Part of Cancer, Lungs & breathing clinical trials.
This study looks at how lung cancer is treated and what it costs in Ontario and Alberta. It uses existing health records to understand patterns and expenses, which can help improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were diagnosed with lung cancer between January 1, 2018 and the end of the study selection period.
- You were 18 or older at the time of your lung cancer diagnosis.
- You had health insurance coverage for at least 12 months before your diagnosis.
- You lived in Ontario or Alberta when you were diagnosed.
- You did not have any other cancer in the 5 years before January 1, 2018, or on the same date as your lung cancer diagnosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the medical records of people with advanced non-small cell lung cancer to understand what treatments they received and whether those treatments follow official guidelines. It may help doctors learn how to improve care for future patients.
This study tracks people diagnosed with lung cancer to learn more about the disease and its treatment in Algeria. By joining, you help build a better understanding of lung cancer care.
This observational study collects information from adults with lung cancer to better understand the disease over time. If you join, it helps researchers learn from real-world experiences rather than testing a new drug.
This study builds a detailed lung-cancer database by collecting clinical and lab information from people newly diagnosed. It aims to help doctors better understand lung cancer and how patients are treated from the start.
This observational study follows adults with newly diagnosed non-small cell lung cancer to understand what treatments are used and how patients are doing. It may help doctors better understand how care decisions affect outcomes, and it does not require the study to give an experimental treatment.
This trial uses real-world data to study how to personalize treatment for advanced non-small cell lung cancer. It looks at medical records from 2011 to 2024 to find the best therapy approaches.
Hear when a new Lung Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.